1314118-94-9 Usage
Biological Activity
mk2 inhibitor iv is a highly selective and non-atp competitive mk2 inhibitor with ic50 value of 0.11 μm [1].map kinase-activated protein kinase 2 (mapkapk2 or mk2) is a member of the ser/thr protein kinase family and regulated through direct phosphorylation by p38 map kinase. activation of the p38/mk2 pathway involved in promoting pro-inflammatory cytokine production and related inflammatory diseases [1].mk2 inhibitor iv is a highly selective and non-atp competitive mk2 inhibitor. in a broad panel of 150 protein kinases, mk2 inhibitor iv only significantly inhibited ck1γ3 at greater than 50%. mk2 inhibitor iv also demonstrated no inhibition against a panel of cytochrome p450 (cyp) enzymes up to 30 μm. in the human thp1 acute monocytic leukemia cell line, mk2 inhibitor iv inhibited pro-inflammatory cytokine secretion. mk2 inhibitor iv also dose-dependently inhibited lps-stimulated tnfα and il6 secretion with ic50 values of 4.4 μm and 5.2 μm, respectively. in the sw1353 chondrosarcoma cell line and human primary chondrocyte cultures, mk2 inhibitor iv dose dependently inhibited il1β-stimulated matrixmetalloprotease (mmp)13 secretion with ic50 values of 5.7 μm and 2.2 μm, respectively.
references
[1]. huang x, shipps gw jr, cheng cc, et al. discovery and hit-to-lead optimization of non-atp competitive mk2 (mapkapk2) inhibitors. acs med chem lett. 2011 jun 24;2(8):632-7.
Check Digit Verification of cas no
The CAS Registry Mumber 1314118-94-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,1,1 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1314118-94:
(9*1)+(8*3)+(7*1)+(6*4)+(5*1)+(4*1)+(3*8)+(2*9)+(1*4)=119
119 % 10 = 9
So 1314118-94-9 is a valid CAS Registry Number.
1314118-94-9Relevant articles and documents
Discovery and hit-to-lead optimization of non-ATP competitive MK2 (MAPKAPK2) inhibitors
Huang, Xiaohua,Shipps, Gerald W.,Cheng, Cliff C.,Spacciapoli, Peter,Zhang, Xingmin,McCoy, Mark A.,Wyss, Daniel F.,Yang, Xianshu,Achab, Abdelghani,Soucy, Kyle,Montavon, Donna K.,Murphy, Denise M.,Whitehurst, Charles E.
, p. 632 - 637 (2011/10/17)
A novel series of non-ATP-competitive MK2 inhibitors based on a furan-2-carboxyamide scaffold was discovered through high-throughput screening using the affinity selection-mass spectrometry-based Automated Ligand Identification System platform. Medicinal
